Heather Creran

Serving in CEO, President, and COO roles, and with experience as a Board Director and Advisor, Heather is a leader with extensive strategic, commercial, and operational success driving growth in diverse enterprises, including startup, joint venture, privately-held and public companies.

Before joining OncoLens, as the Principal of Health Acuity Consulting, she engaged in strategic and tactical projects in healthcare data, insights, and diagnostics. Her prior roles include; Chief Operating Officer at Lineagen, an independent, privately-held, genetics testing company for children with autism spectrum disorder, concurrent roles as President and Board Director for Eurofins Scientific’s US Clinical Diagnostics Division at both EGL Genetics, a joint venture between Eurofins and Emory University, internationally recognized in rare and inherited disease genetic testing, and NTD, in the pre-natal screening market, President & CEO of CSI Laboratories, an independent, privately held national cancer diagnostics company, and Executive Vice President and Chief Operating Officer at Clarient, Inc., a NASDAQ traded, personalized medicine company.

Heather serves as a Georgia Research Alliance Senior Advisor, and on advisory boards and committees with industry, non-profit, and government organizations. She received her B.A. with majors in Economics and Political Science from Duke University.